4.6 Article

Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine (FRB!)

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis

Ursula Schmidt-Erfurth et al.

Summary: Deep learning methods allow accurate assessment of the therapeutic response to brolucizumab and aflibercept in neovascular age-related macular degeneration. Residual volumes of intraretinal fluid, subretinal fluid, and pigment epithelial detachment are associated with visual loss.
Article Ophthalmology

SYSTEMATIC CORRELATION OF CENTRAL SUBFIELD THICKNESS WITH RETINAL FLUID VOLUMES QUANTIFIED BY DEEP LEARNING IN THE MAJOR EXUDATIVE MACULAR DISEASES

Maximilian Pawloff et al.

Summary: This study investigated the correlation between volumetric measurements of intraretinal and subretinal fluid obtained by deep learning and central retinal subfield thickness based on optical coherence tomography in different retinal diseases. The findings suggest that the correlation of central retinal subfield thickness (CSFT) and fluid volumes depends on the underlying pathology, with limited impact in patients with neovascular age-related macular degeneration.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2022)

Article Multidisciplinary Sciences

Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration

Philipp K. Roberts et al.

Summary: This study aimed to find baseline predictors for subretinal fibrosis (SF) in neovascular age-related macular degeneration (nAMD). Through various imaging techniques and quantitative feature evaluations, low baseline BCVA, intraretinal fluid, and subretinal hyperreflective material were identified as easily identifiable baseline parameters indicating increased risk.

SCIENTIFIC REPORTS (2022)

Article Ophthalmology

Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)-a phase III, prospective, multicentre, randomized study: design and methods

Leonard M. Coulibaly et al.

Summary: In neovascular age-related macular degeneration (nAMD), the implementation of an AI algorithm for automated real-time fluid quantification shows promise in improving disease management and reducing injection numbers, thus relieving healthcare burden.
Article Ophthalmology

Evaluation of a self-imaging SD-OCT system designed for remote home monitoring

Judy E. Kim et al.

Summary: This study compared the performance of the NVHO device and a commercial OCT device in identifying retinal fluid in patients with age-related macular degeneration. The results showed that the NVHO device can produce high-quality images suitable for fluid identification, suggesting its potential to complement standard clinical assessments and treatments.

BMC OPHTHALMOLOGY (2022)

Article Medicine, General & Internal

Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence

Hrvoje Bogunovic et al.

Summary: This study used a machine learning model based on quantitative OCT imaging biomarkers to predict visual outcomes and treatment needs in patients with neovascular age-related macular degeneration (nAMD) undergoing a treat & extend (T&E) regimen. The model successfully predicted treatment intervals and visual outcomes using OCT features and clinical information, providing evidence for the potential use of AI in managing patients with nAMD.

FRONTIERS IN MEDICINE (2022)

Article Ophthalmology

Impact of Intra- and Subretinal Fluid on Vision Based on Volume Quantification in the HARBOR Trial

Sophie Riedl et al.

Summary: In patients with neovascular age-related macular degeneration (nAMD), there is a correlation between intraretinal fluid (IRF) and subretinal fluid (SRF) volumes and best-corrected visual acuity (BCVA). After the first injection, a decrease in IRF is associated with an increase in BCVA, while a decrease in SRF is associated with significant vision improvement.

OPHTHALMOLOGY RETINA (2022)

Article Ophthalmology

FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Fight Retinal Blindness! Project

Elisa E. Cornish et al.

Summary: The study compared treatment intensity and visual acuity gains for first- and second-affected eyes with age-related macular degeneration over 5 years. It found that second-affected eyes had higher visual acuity gains but received fewer treatments and reactivated earlier. Care should be taken to avoid undertreating second-affected eyes.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

Article Ophthalmology

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD

Usha Chakravarthy et al.

Summary: The study reveals that greater fluctuations in retinal fluid volumes during the maintenance phase of anti-VEGF treatment in nAMD are associated with worse visual acuity by 2 years.
Article Ophthalmology

Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Degeneration

Tiarnan D. L. Keenan et al.

Summary: The study evaluated the use of artificial intelligence algorithms to extract retinal fluid volume data from OCT scans for treatment of NVAMD. The results showed rapid decrease in fluid volumes with anti-VEGF therapy, and the importance of quantitative measures of IRF, SRF, and PED as biomarkers in NV-AMD. Using nanoliters as a convenient unit for consistency between studies is proposed.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Ophthalmology

Predicting Incremental and Future Visual Change in Neovascular Age-Related Macular Degeneration Using Deep Learning

Dun Jack Fu et al.

Summary: This study evaluated the predictive usefulness of quantitative imaging biomarkers acquired automatically from OCT scans in patients with neovascular AMD undergoing anti-VEGF therapy. The results indicate the potential of these biomarkers to predict visual outcomes and inform treatment decisions for personalized medicine.

OPHTHALMOLOGY RETINA (2021)

Article Ophthalmology

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions

Mark Gillies et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)

Article Ophthalmology

Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT

Tiarnan D.L. Keenan et al.

OPHTHALMOLOGY (2020)

Article Ophthalmology

Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: An Analysis of the IRIS Registry

Allen C. Ho et al.

OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2020)

Article Ophthalmology

Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach

Hrvoje Bogunovic et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Article Ophthalmology

A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration

Ursula Schmidt-Erfurth et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2016)

Article Ophthalmology

EFFICIENT CAPTURE OF HIGH-QUALITY DATA ON OUTCOMES OF TREATMENT FOR MACULAR DISEASES The Fight Retinal Blindness! Project

Mark C. Gillies et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)

Article Ophthalmology

Subfoveal Fibrosis in Eyes With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab

Sara Brandi Bloch et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)

Article Computer Science, Artificial Intelligence

Optimal surface segmentation in volumetric images - A graph-theoretic approach

K Li et al.

IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2006)